Download presentation
Presentation is loading. Please wait.
1
PI-Based HCV-1 Therapy: Reasons to Hold Off
2
SPRINT-2: Overall SVR Rates
3
ADVANCE: Overall SVR and Relapse Rates
4
RESPOND-2 SVR Rates According to Treatment Arm and Prior Response
5
REALIZE: SVR According to Previous Response
6
Telaprevir Adverse Events and Discontinuations
7
Boceprevir: Adverse Events and Discontinuations
8
HCV Drug Pipeline
9
SPRINT-2: Response Rates According to Race
10
SPRINT-2: SVR in Advanced Fibrosis/Cirrhosis
11
ADVANCE Response Rates According to Race/Cirrhosis
12
RESPOND-2 SVR in Advanced Fibrosis/Cirrhosis
13
REALIZE: SVR by Baseline Fibrosis Stage and Previous Response
14
Treatment for F3-F4?
15
Treatment decision
16
Thank you!
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.